Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -3.98% is 98% above its 5-year average of -208.07%, near the high end of its 5-year range (-1905.15%–48.67%).
87.91% above its 12-month average of -32.92%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 42.30%.
OPERATING MARGIN
-3.98%
OPERATING MARGIN AVG TTM
-32.92%
OPERATING MARGIN AVG 3Y
-223.57%
OPERATING MARGIN AVG 5Y
-208.07%
OPERATING MARGIN AVG 10Y
-64.88%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+87.91%
CURRENT VS 3Y AVG
+98.22%
CURRENT VS 5Y AVG
+98.09%
CURRENT VS 10Y AVG
+93.87%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Zevra Therapeutics, Inc.
Market Cap
$634.30M
Operating Margin
-3.98%
TTM Avg
-32.92%
3Y Avg
-223.57%
5Y Avg
-208.07%
Market Cap
$632.16M
Operating Margin
-4498.06%
TTM Avg
-5642.71%
3Y Avg
-2821.36%
5Y Avg
-1883.89%
Market Cap
$630.63M
Operating Margin
-383.15%
TTM Avg
-332.73%
3Y Avg
-228.44%
5Y Avg
-187.72%
Market Cap
$638.20M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$619.15M
Operating Margin
-85.01%
TTM Avg
-96.97%
3Y Avg
-124.64%
5Y Avg
-134.49%
Market Cap
$656.59M
Operating Margin
-187.24%
TTM Avg
-253932.81%
3Y Avg
-127981.70%
5Y Avg
-85456.42%
Market Cap
$657.89M
Operating Margin
-4.44%
TTM Avg
-7.18%
3Y Avg
-7.18%
5Y Avg
-7.18%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zevra Therapeutics, Inc. (ZVRA) | $634.30M | -3.98% | -32.92% | -223.57% | -208.07% |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | -4498.06% | -5642.71% | -2821.36% | -1883.89% |
| OmniAb, Inc. (OABI)vs › | $630.63M | -383.15% | -332.73% | -228.44% | -187.72% |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.15M | -85.01% | -96.97% | -124.64% | -134.49% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $656.59M | -187.24% | -253932.81% | -127981.70% | -85456.42% |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | 0.00% | 0.00% | 0.00% | 0.00% |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | -4.44% | -7.18% | -7.18% | -7.18% |
| Annexon, Inc. (ANNX)vs › | $660.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | 317.06% | -14996.68% | -12629.31% | -15360.40% |
Gross Margin
84.5%
Operating Margin
-4.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 42.30% |
| 2026-03-31 | 24.38% |
| 2025-12-31 | 27.30% |
| 2025-09-30 | 15.90% |
| 2025-06-30 | -274.48% |
| 2025-03-31 | -26.28% |
| 2024-12-31 | -128.01% |
| 2024-09-30 | -739.00% |
| 2024-06-30 | -534.84% |
| 2024-03-31 | -598.13% |
| 2023-12-31 | -111.00% |
| 2023-09-30 | -530.71% |
| 2023-06-30 | -73.81% |
| 2023-03-31 | -404.00% |
| 2022-12-31 | -399.01% |
| 2022-09-30 | -230.55% |
| 2022-06-30 | -1905.15% |
| 2022-03-31 | -46.89% |
| 2021-12-31 | -110.07% |
| 2021-09-30 | -113.08% |
| 2021-06-30 | 48.67% |
| 2021-03-31 | 57.44% |
| 2020-12-31 | -135.84% |
| 2020-09-30 | -63.01% |
| 2020-06-30 | 37.54% |
| 2020-03-31 | -180.71% |
| 2019-12-31 | -320.49% |
| 2019-09-30 | 28.21% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
